Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking Selenium Chemical Space via a Programmable Synthesis Platform Bearing Cannabinoid Receptor Recognition Motifs.

Journal of the American Chemical Society·2026
Same author

Genetically Encoded CB<sub>2</sub>R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators.

International journal of molecular sciences·2026
Same author

A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (<i>S</i>-MRI-1867/Zevaquenabant).

Molecules (Basel, Switzerland)·2026
Same author

Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.

Molecular psychiatry·2025
Same author

Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders.

Journal of medicinal chemistry·2025
Same author

CB<sub>1</sub> receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice.

Molecular psychiatry·2025

Related Experiment Video

Updated: Jun 26, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K

Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor.

Samay Shivshankar1, Josephine Nimely1, Henry Puhl2

  • 1Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA.

International Journal of Molecular Sciences
|May 11, 2024
PubMed
Summary

This study characterizes the GRABeCB2.0 sensor, revealing how its fluorescence changes with various cannabinoid ligands. This enhances its use for studying endocannabinoid signaling in real-time.

Keywords:
2-AGAEACB1RCB2RGRABeCB2.0allostericorthosteric

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.7K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Cannabinoid receptors (CB1R and CB2R) are key targets for endocannabinoids (eCBs) like 2-AG and AEA, influencing numerous physiological processes.
  • The recently developed GRABeCB2.0 sensor enables real-time monitoring of eCB levels in biological systems.
  • Limited characterization exists for GRABeCB2.0's response to synthetic cannabinoid agents, including antagonists and allosteric modulators.

Purpose of the Study:

  • To expand the pharmacological characterization of the GRABeCB2.0 sensor.
  • To understand how GRABeCB2.0 fluorescence signals change in response to diverse cannabinoid ligands.
  • To improve the utility of GRABeCB2.0 for in vitro and in vivo cannabinoid research.

Main Methods:

  • Utilized the GRABeCB2.0 sensor to detect changes in endocannabinoid signaling.
  • Administered various synthetic cannabinoid ligands, including antagonists and allosteric modulators.
  • Monitored and analyzed alterations in fluorescent signals generated by the GRABeCB2.0 sensor.

Main Results:

  • Demonstrated distinct fluorescent signal changes in GRABeCB2.0 in response to different cannabinoid ligands.
  • Provided a more comprehensive understanding of GRABeCB2.0's pharmacological profile.
  • Established the sensor's responsiveness to a range of cannabinoid receptor modulators.

Conclusions:

  • The enhanced characterization of GRABeCB2.0 expands its utility for studying cannabinoid receptor pharmacology.
  • Results support the use of GRABeCB2.0 for real-time monitoring of endocannabinoid system activity.
  • This work may facilitate the development of novel cannabinoid-based therapeutics.